Sy Mukherjee, Fortune

Sy Mukherjee


New York, NY, United States

Contact Sy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Fortune

Recent articles by Sy:

These 6 Cannabis Stocks Shot Up After Canada Legalized Marijuana

Marijuana company shares are on a high following the landmark legalization. → Read More

Meet Atul Gawande, the Surgeon Who Will Lead the Amazon-JPMorgan-Berkshire Health Venture

The Amazon-JPMorgan-Berkshire Hathaway health care venture has named its CEO: Dr. Atul Gawande, prominent surgeon and public health expert. → Read More

Brainstorm Health: Sarepta Duchenne Therapy, CVS Drug Delivery, Trump's New Obamacare Move

Hello, readers—This is Sy. Shares of biotech Sarepta Therapeutics shot off to the moon Tuesday after the company announced early data on its experimental gene therapy to treat Duchenne muscular dystrophy. Sarepta stock was up as much as 67% during trading, settling closer to a 35% bump later in the afternoon, or just under $140 per share. The investor frenzy was galvanized by some promising,… → Read More

Why Sarepta Stock Skyrocketed 40% Today

Sarepta stock skyrocketed more than 40% in Tuesday trading as investors cheered early data for its muscular dystrophy gene therapy drug. → Read More

Valeant Stock Was Having a Pretty Good 2018—Until Today

Valeant shed 8% of its market value on Monday. Here's why. → Read More

There's a Plant Called 'Giant Hogweed' and It Can Cause Blindness and Third Degree Burns

Giant hogweed has reportedly been found in Virginia, local officials said. Here's what to know about the blindness and burn-causing plant. → Read More

The WHO Just Classified 'Gaming Disorder' As a Mental Health Condition. But Should It?

The WHO has classified "gaming disorder" as a mental health condition under ICD-11. But some experts aren't so sure it should be. → Read More

The WHO Just Classified 'Gaming Disorder' As a Mental Health Condition. But Should It?

The WHO has classified "gaming disorder" as a mental health condition under ICD-11. But some experts aren't so sure it should be. → Read More

Brainstorm Health: Gaming Disorder, Valeant Stock, Migrant Family Separation and Health

I hope you’ve had a wonderful weekend, readers. This is Sy. It’s not every day that a group as significant as the World Health Organization (WHO) adds a whole new disorder to its official classification of diseases, appropriately dubbed the “International Classification of Diseases” (which is now on its 11th edition, or ICD-11). Well, today is one of those days. The WHO is officially classifying… → Read More

The CDC Says U.S. Teens Are Having Less Sex, Doing Fewer Drugs—But Feeling More Depressed

It's the latest disturbing finding about suicide and mental health in America. → Read More

All That Business Travel May Be Making You Physically and Mentally Sick, Study Says

Researchers found a "strong correlation" between frequent business travel and multiple chronic diseases. → Read More

A Party During a Major Biotech Conference Featured Topless Dancers — And Is Drawing Heavy Criticism

Dancers had the party sponsor's logos painted onto their bodies. → Read More

Harvard Pilgrim's CEO Just Abruptly Resigned Over 'Behavior'

Harvard Pilgrim is one of the largest health insurance companies in Massachusetts. → Read More

Eli Lilly, AstraZeneca's Alzheimer's Drug Flop Is the Latest Disappointment in a Frustrating Disease

Eli Lilly and AstraZeneca are ditching an experimental Alzheimer's drug. It's the latest in a string of failures in the field. → Read More

Brainstorm Health: Alzheimer's Drug Failures, Sage Therapeutics Stock, Azar on Drug Prices

Good afternoon, readers—This is Sy. Of the diseases that regularly afflict millions upon millions of Americans, few have been quite as nefarious as Alzheimer’s when it comes to defying drug developers’ most ardent efforts. That trend continued Tuesday as Indianapolis-based Eli Lilly and partner AstraZeneca of the U.K. threw in the towel on late-stage clinical trials for an Alzheimer’s medicine… → Read More

Trump's War on Obamacare's Pre-Existing Conditions Rules Could Be a Boon to Democrats

The administration is taking aim at popular Obamacare provisions going into the midterm elections. → Read More

We Just Got Details on What the Combined CVS-Aetna Management Will Look Like

CVS and Aetna are pulling back the curtain on executive leadership plans once the $69 billion merger closes. Aetna executives will stay. → Read More

Athenahealth CEO Jonathan Bush Steps Down Following Reports of Inappropriate Behavior

Athenahealth CEO Jonathan Bush is stepping down effective immediately. The move follows reports of inappropriate workplace behavior. → Read More

Opioid Overdose Antidote Naloxone's Recall Is the Latest Black Eye for Pfizer Unit Hospira

Pfizer's Hospira arm has been at the heart of multiple supply chain breakdowns. → Read More

Tens of Thousands of Early Breast Cancer Patients May Not Need Chemo After All

According to a groundbreaking new study presented at cancer conference ASCO. → Read More